Semicarnazide-sensitive amine oxidase: Current status and perspectives

Current Medicinal Chemistry

Volumn 11, Issue 10, 2004, Pages 1285-1298

  Matyus P ^a   Dajka Halasz B ^a   Foldi A ^a   Haider, N ^b   Barlocco, D ^c   Magyar, K ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Atherosclerosis; Diabetes; Haloalkylamines; Haloallylamines; Hydrazines; Inhibitors; Semicarbazide sensitive amine oxidase (ssao); VAP 1

Indexed keywords

ALDEHYDE; ALIPHATIC AMINE; ALLYLAMINE DERIVATIVE; AMIFLAMINE; AMINE OXIDASE (COPPER CONTAINING); AMINOGUANIDINE; AMMONIA; ARALKYLAMINE; BENSERAZIDE; BENZYLAMINE DERIVATIVE; CARBIDOPA; CLORGYLINE; HYDRALAZINE; HYDRAZINE DERIVATIVE; HYDROGEN PEROXIDE; IPRONIAZID; ISONIAZID; METHYLAMINE; MEXILETINE; MOFEGILINE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; NIALAMIDE; ORGANOHALOGEN DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PHENELZINE; PHENYLHYDRAZINE; PROCARBAZINE; SEMICARBAZIDE; UNINDEXED DRUG; ENZYME INHIBITOR;

AEROBIC METABOLISM; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BRAIN INFARCTION; CATALYSIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEAMINATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE SEVERITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME SUBSTRATE; HUMAN; LIVER CIRRHOSIS; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; STRUCTURE ACTIVITY RELATION; UREMIA; ARTERIOSCLEROSIS; BLOOD; BLOOD VESSEL; CHEMICAL STRUCTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; PHYSIOLOGY;

AMINE OXIDASE (COPPER-CONTAINING); ARTERIOSCLEROSIS; BLOOD VESSELS; DIABETES MELLITUS; ENZYME INHIBITORS; HUMANS; MOLECULAR STRUCTURE;

EID: 7444237590     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867043365305     Document Type: Review

References (82)

1. Lyles, G. A. Int. J. Biochem. Cell Biol., 1996, 28, 259.
2. Yu, P. H.; Tipton, K. F.; Boulton, A. A. Prog. Brain. Res., 1995, 106, 323.
3. Magyar, K.; Mészáros, Z.; Mátyus, P. Pure Appl. Chem., 2001, 73, 1393.
4. Yu, P. H.; Davis, B. A.; Boulton, A. A.; Zuo, D. M. J. Neural Transm. (Suppl)., 1994, 41. 397.
5. Lyles, G. A.; J. Neural Transm (Suppl)., 1994, 41, 387.
6. Callingham, B. A; Holt, A.; Elliott, J. Biochem. Soc. Trans., 1991, 19, 228.
7. Boomsma, F. Neurobiology, 2000, 8, 1.
8. Raimondi, L.; Conforti, L.; Banchelli, G.; Sgromo, L.; Pirisino, R. J. Pharm. Pharmacol., 1997, 49, 542.
9. Lizcano, J. M.; Unzeta, M. Neurobiology, 2000, 8, 37.
10. Holt, A.; Alton, G.; Scaman, C. H. Loppnow, G. R.; Szpacenko, A.; Svendsen, I.; Palcic, M.M. Biochemistry, 1998, 37, 4946.
11. Mészáros, Zs.; Csányi, A.; Vallus, G.; Szombathy, T.; Karádi, I.; Magyar, K. Neurobiology, 2000, 8, 215.
12. Raimondi, L.; Conforti, L; Banchelli, G.; Ignesti, G.; Pirisino, R.; Buffoni, F. Biochem. Pharmacol., 1993, 46, 1369.
13. Buffoni, F.; Cambi, S.; Banchelli, G.; Ignesti, G.; Prisino, R.; Raimondi, L. J. Neural Transm. (Suppl)., 1994, 41. 421.
14. Arriba, A. F.; Balsa, D.; Tipton, K. F.; Unzeta, M. J. Neural Transm (Suppl)., 1990, 32, 327.
15. Castillo, V.; Lizcano, J. M.; Visa, J.; Unzeta, M. Neurochem. Int., 1998, 33, 415.
16. Yu, P. H.; Zuo, D. M.; Davis, B. A. Biochem. Pharmacol., 1994, 47, 1055.
17. Dijk, J.; Boomsma, F.; Alberts, G.; Man in't Veld, A.J.; Schlekamp, M.A.D.H. J. Chromatogr. B., 1995, 663, 43.
18. Andrés, N.; Lizcano, J. M.; Rodríguez, M. J.; Romera, M.; Unzeta, M.; Mahy, N. J. Histochem. Cytochem., 2001, 49, 209.
19. Langford, S. D.; Trent, M. B.; Balakumaran, A.; Boor, P. J. Toxicol. Appl. Pharmacol., 1999, 155, 237.
20. Exner, M.; Hermann, M.; Hofbauer, R.; Kapiotis, S.; Quehenberger, P.; Speiser, W.; Held, I.; Gmeiner, B. M. K. Cardiovasc. Res., 2001, 50, 583.
21. Yu, P. H.; Zuo, D. M. Atherosclerosis, 1996, 120, 189.
22. Lizcano, J. M.; Arriba, A. F.; Tipton, K. F.; Unzeta, M. Biocem. Pharmacol., 1996, 52. 187.
23. Kurkijarvi, R.; Adams, D. H.; Leino, R.; Mottonen, T.; Jalkanen, S.; Salmi, M. J. Immunol., 1988, 161, 1549.
24. Smith, D. J.; Salmi, M.; Bono, P.; Hellman, J.; Leu, T.; Jalkanen, S. J. Exp. Med. 1998, 188, 1.
25. Mészáros, Z.; Szombathy, T.; Raimondi, L.; Karádi, I.; Romics, L.; Magyar, K. Metabolism, 1999, 48, 113.
26. Mészáros, Z.; Romics, L.; Magyar, K. Eur. J. Drug Metab. Pharmacokinet., 1999, 24, 299.
27. Boomsma, F.; van Veldhuisen, D. J.; de Kam, P. J.; Man in 't Veld, A. J.; Mosterd, A.; Lie, K. I.; Schalekamp, M. A. D. H. Cardiovasc. Res., 1997, 33, 387.
28. Yu, P. H. Eur. Heart J., 2000, 21, 1812.
29. Boomsma, F.; Derkx, F. H. M.; van den Meiracker, A. H.; Man in 't Veld, A. J.; Schalekamp, A. M. Clin. Sci., 1995, 88, 675.
30. Ishizaki, F. Eur. Neurol., 1990, 30, 104.
31. Levinsohn, R. Pharmacol. Res. Commun. (Suppl. IV), 1988, 20, 45.
32. McEwen Jr., C. M.; Castell, D. O. J. Lab. Clin. Med., 1967, 70, 36.
33. Kurkijarvi, R.; Yegutkin, G. G.; Gunson, B. K.; Jalkanen, S.; Salmi, M.; Adams, D. H. Gastoenterology, 2000, 119, 1096.
34. Levinsohn, R. Clin. Chim. Acta, 1977, 81, 247.
35. Nilsson, S. E.; Tryding, N.; Tufvesson, G. Acta. Med. Scand., 1968, 184, 105.
36. Boomsma, F.; van den Meiracker, A. H.; Winkel, S.; Aanstoot, H.J.; Batstra, M.R.; Man in 't Veld, A. J.; Bruining, G. J. Diabetologia, 1999, 42, 233.
37. Hayes, B. E.; Clarke, D. E. Res. Commun. Chem. Pathol. Pharmacol., 1990, 69, 71.
38. Lyles, G. A.; Chalmers, J. Biochem. Pharmacol., 1995, 49, 416.
39. Yu, P. H.; Zuo, D. M. Diabetes, 1993, 42, 594.
40. Yu, P. H.; Zuo, D. M. Diabetologia, 1997, 40, 1243.
41. Yu, P. H.; Davis, B. A.; Boulton, A. A.; Zuo, D. M. J. Neural Transm. (Suppl.), 1994, 41, 397.
42. Ekblom, J. Pharmacol. Res., 1998, 37, 2, 87.
43. Yu, P. H. J. Neural Transm. (Suppl.), 1998, 52, 201.
44. Grönvall, J. L. E.; Garpenstrand, H.; Oreland, L.; Ekblom, J. Life Sci., 1998, 63, 9. 759.
45. Deng, Y.; Boomsma, F.; Yu, P. H. Life Sci., 1998, 63, 23. 2049.
46. Deng, Y.; Yu, P. H. J. Chromatogr. Sci., 1999, 37, 317.
47. Yu, P. H.; Deng, Y. L. Atherosclerosis, 1998, 140, 357.
48. Yu, K. T.; Khalaf, N.; Czech, M. P. J. Biol. Chem., 1987, 262, 7865.
49. Seregi, A.; Serfözö, P.; Mergl, Z.; Schaefer, A. J. Neurochem. 1982, 38, 20.
50. Thornalley, P. J. Amino Acids, 1994, 6, 15.
51. Enrique-Tarancón, G.; Marti, L.; Morin, N.; Lizcano, J. M.; Unzeta, M.; Sevilla, L.; Camps, M.; Palacín, M.; Testar, X.; Carpéné, C.; Zorzano, A. J. Biol. Chem., 1998, 273, 8025.
52. Moldes, M.; Feve, B.; Pairault, J. J. Biol. Chem., 1999, 274, 9515.
53. Enrique-Tarancón, G.; Castan, I.; Morin, N.; Marti, L.; Abella, A.; Camps, M.; Casamitjana, R.; Palacín, M.; Testar, X.; Degerman, E.; Carpéné, C.; Zorzano, A. Biochem. J., 2000, 350, 171.
54. Haller, H.; Schaper, D.; Ziegler, W.; Philipp, S.; Kuhlmann, M.; Distler, A.; Luft, F.C. Hypertension, 1995, 25, 511.
55. Vlassara, H.; Fuh, H.; Donnelly, T.; Cybulsky, M. Mol. Med., 1995, 1, 447.
56. Crosbie, A. E.; Callingham, B. A. J. Neural Transm. (Suppl.), 1994, 41, 427.
57. Holt, A.; Sharman, D. F.; Callingham, B. A.; Kettler, R. J. Pharm. Pharmacol., 1992, 44, 487.
58. Holt, A.; Callingham, B. A. J. Neural Transm. (Suppl.), 1994, 41, 439.
59. Smith, D. J.; Jalkanen, M.; Fülöp, F.; Lázár, L.; Szakonyi, Zs.; Bernáth, G. Patent, 2002, WO 0202090.
60. Smith, D. J.; Jalkanen, M.; Fülöp, F.; Lázár, L.; Szakonyi, Zs.; Bernáth, G. Patent, 2002, WO 0202541.
61. Buffoni, F.; Bertini, V.; Dini, G. J. Enzyme Inhibition, 1998, 13, 253.
62. Fowler, C. J.; Eriksson, M.; Thorell, G.; Magnusson, O. Naunyn-Schmiedeberg's Arch. Pharmacol., 1984, 327, 279.
63. Morikawa, F.; Ueda, T.; Arai, Y.; Kinemuchi, H. Pharmacology, 1986, 32, 38.
64. Eriksson, M.; Fowler, C. J. Naunyn-Schmiedeberg's Arch. Pharmacol., 1984, 327, 273.
65. Lyles, G. A.; Marshall, C. M. S.; McDonald, I. A.; Bey, P.; Palfreyman, M. G. Biochem. Pharmacol., 1987, 36, 2847.
66. Lyles, G. A.; Marshall, C. M. S.; Flucker, C. J. R. Biochem. Pharmacol., 1989, 38, 2937.
67. Elliott, J.; Callingham, B. A.; Barrand, M. A. J. Pharm. Pharmacol., 1989, 41, 37.
68. Palfreyman, M. G.; McDonald, I. A.; Bey, P.; Danzin, C.; Zreika, M.; Cremer, G. J. Neural Transm (Suppl)., 1994, 41. 407.
69. Banchelli, G.; Bertocci, B.; Buffoni, F. Pharmacol. Res. Commun. (Suppl. IV), 1988, 20, 165.
70. Cornish-Brown, A. Analysis of Enzyme Kinetic Data; Oxford University Press: Oxford, 1995.
71. Yu, P. H.; Fang, C.-Y.; Yang, C.-M. J. Pharm. Pharmacol., 1992, 44, 981.
72. Conn, C.; Shimmon, R.; Cordaro, F.; Hargraves, T.-L.; Ibrahim, P. Bioorg. Med. Chem. Lett., 2001, 11, 2565.
73. Kinemuchi, H.; Jinbo, M.; Akiba, A.; Tabata, M.; Toyoshima, Y.; Arai, Y.; Tadano, T.; Kisara, K.; Oreland, L. Jpn. J. Pharmacol., 2000, 83, 164.
74. Kinemuchi, H.; Kobayashi, N.; Takahashi, K.; Takayanagi, K.; Arai, Y.; Tadano, T.; Kisara, K.; Oreland, L. Arch. Bioch. Biophys., 2001, 385, 154.
75. Yu, P. H.; Davis, B. A.; Deng, Y. Biochem. Pharmacol., 2001, 61, 741.
76. Dostert, P.; Guffroy, C.; Strolin Benedetti,M.; Boucher, T. J. Pharm. Pharmacol., 1984, 36, 782.
77. Obata, T.; Yamanaka, Y. Neurosci. Lett., 2000, 286, 131.
78. Caldirola, P.; Besencon, O.; Olsson, R.; Öhman, J. Patent, 2002, WO 0238153.
79. Scarponi, U.; Cimaschi, R.; De Castiglione, R.; Verini, A. Patent, 1985, DE 3521303.
80. Arcari, G.; Bernardi, L.; Falconi, G.; Scarponi, U. Patent, 1979, BE 871985.
81. Boomsma, F.; van den Meiracker, A.; Man in't Veld, A. J.; Schalekamp, M. Life Sci., 1995, 57, 19. 1753.
82. Dijk, J.; Boomsma, F. Clin. Chim. Acta, 1998, 270, 189.